Table 2.
Adjusted average daily gain (kg) for each study group by time periods, with standard error mean (SEM) across all study groups.
| Time period | Average daily gains (kg) | p-value (Study group) | ||||
|---|---|---|---|---|---|---|
| CONT | IO | RPO | CV | SEM | ||
| On milk (aged 3–11 weeks) | 0.70a | 0.64ab | 0.61b | 0.67ab | 0.026 | 0.077 |
| Post-weaning (aged 12–15 weeks) | 0.79ab | 0.72a | 0.75ab | 0.85b | 0.041 | 0.103 |
| Post-parenteral vaccination (aged 16–18 weeks) | 1.11 | 0.90 | 0.89 | 0.83 | 0.110 | 0.279 |
| Start to finish (aged 3–18 weeks) | 0.77a | 0.69b | 0.69b | 0.74ab | 0.023 | 0.031 |
On milk, weeks 1–7 on trial; post-weaning, weeks 8–12 on trial; post-parenteral vaccination, weeks 13–14 on trial; start to finish, weeks 1–14 on trial. Where study groups that share a letter differences are non-significant. Controls (CONT), vaccinated with just Bovilis IBR Marker Live® (IO), vaccinated with just Bovilis INtranasal RSP Live® (RPO), and vaccinated concurrently with both Bovilis INtranasal RSP Live® and Bovilis IBR Marker Live® (CV).